Riskpilot← Back to searchSign inGet full accessCellMark Raw Materials AB
ABIn liquidationOrg 5564118809Wholesale of motor vehicle parts and accessories · NACE 4672Est. 19901 employees
Revenue 2023
SEK 12K
-100% vs 2022
EBITDA margin
125625.0%
+1768% vs 2022
Equity ratio
96.7%
Financial strength
Net profit 2023
SEK 11,9M
+3280% vs 2022
| Revenue | SEK 12K | -100% |
| EBITDA | SEK 15,1M | +1768% |
| Net profit | SEK 11,9M | +3280% |
| Total assets | SEK 12,8M | -20% |
| Equity | SEK 12,4M | +2522% |
| Employees | 1 | — |
Legal name
CellMark Raw Materials AB
Org number
5564118809
Legal form
Aktiebolag
NACE code
4672 · Wholesale of motor vehicle parts and accessories
Founded
23 november 1990
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolagets verksamhet ska vara att bedriva handel med metaller, ferrolegeringar, malmer, kol, koks samt andra råvaror,samt import, export, lagerhållning, distribution och handel med möbler, skulpturer i sten och trä, heminredningsprodukter, familje- och andra spel, elektroniska apparater och utrustning, båtar, vattenskoters och instrument för sjön samt livsmedel, samt förvaltning av lös och fast egendom.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 924 925 | 753 774 | 929 000 | 1 399 290 | 19 046 | 12 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −1 231 | 14 138 | −20 323 | 15 629 | 2 144 | −13 267 | 17 875 | 807 | 15 075 |
| Depreciation & amort. | −18 | −18 | −4 | −10 | −0 | −0 | −0 | −111 | −0 |
| EBIT | −1 249 | 14 120 | −20 327 | 15 619 | 2 144 | −13 267 | 17 875 | 696 | 15 075 |
| Net financials | −1 156 | 493 | −4 500 | −5 817 | −4 606 | −3 153 | −3 474 | −77 | −48 |
| Profit before tax | 181 | 213 | −8 073 | 9 802 | 10 138 | 4 947 | 20 801 | 619 | 15 027 |
| Tax | −54 | −133 | −25 | −2 157 | −2 263 | −1 213 | −2 630 | −266 | −3 097 |
| Net profit | 127 | 80 | −8 098 | 7 645 | 7 875 | 3 734 | 18 171 | 353 | 11 930 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 274 922 | 174 064 | 280 356 | 231 268 | 250 903 | 258 569 | 123 974 | 15 932 | 12 822 |
| Equity | 30 382 | 30 462 | 22 364 | 30 009 | 37 884 | 41 618 | 18 292 | 473 | 12 403 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 241 186 | 141 848 | 257 992 | 201 259 | 210 219 | 212 551 | 105 682 | 15 459 | 419 |
| Total debt | 241 186 | 141 848 | 257 992 | 201 259 | 210 219 | 212 551 | 105 682 | 15 459 | 419 |
EBITDA margin
125625.0%
This company
15.8%
Market median
+794995% vs market
20152023
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
20152023
Return on equity
96.2%
This company
18.4%
Market median
+423% vs market
20152023
Net profit margin
99416.7%
This company
8.1%
Market median
+1227267% vs market
20152023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152023
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KH Liquidator | Liquidator | 2020 | — | — |
JM Audit | Audit | 2021 | — | — |
TP External Signatory | External Signatory | 2020 | — | — |
CT Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
FD Audit | Audit | 2021 | — | — |
MR Liquidator | Liquidator | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CellMark Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CellMark Investment AB
CellMark Raw Materials AB Board members of CellMark Raw Materials AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Helene Schurmann | Liquidator | 0 companies |
| Johan Mikael Pauli | Audit | 0 companies |
| Thord Peter Karsberg | External Signatory | 0 companies |
| Claes Thomas Lundman | Chief Executive Officer | 0 companies |
| Filip David Larsson | Audit | 0 companies |
| Mikael Rickard Kowal | Liquidator | 0 companies |
| Pär Johan Ingvar Olsson Rafstedt | Chairman | 0 companies |